Nektar Therapeutics | NKTR - Capital Social Ordinario

Precio De Mercado
77.50
Cambio Diario
-0.35 -0.45%
Mensual
5.69%
Anual
736.44%
Q2 Expectativa
75.38




Capital Social Ordinario Cambio Fecha
Agios Pharmaceuticals USD 58.45M 169K 2025-12
ALKERMES USD 165.61M 503K 2025-12
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 539M 1000K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 9.38M 9.38M 2025-09
Cipla INR 807.77M 807.43M 2025-09
Dr.Reddys Laboratories INR 832.52M 144K 2025-09
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Exelixis USD 268.1M 2.03M 2025-09
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
Takeda JPY 1.58B 2K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xencor USD 71.87M 529K 2025-12